Works matching IS 15257304 AND DT 2024 AND VI 25 AND IP 6

Results: 12

MDT-BRIDGE: Neoadjuvant Durvalumab Plus Chemotherapy Followed by Either Surgery and Adjuvant Durvalumab or Chemoradiotherapy and Consolidation Durvalumab in Resectable or Borderline-resectable Stage LIB-ILIB NSCLC.

Published in:

Clinical Lung Cancer, 2024, v. 25, n. 6, p. 587, doi. 10.1016/j.cllc.2024.06.007

By:

Reck, Martin;
Nadal, Ernest;
Girard, Nicolas;
Filippi, Andrea R.;
Martin, Linda W.;
Gay, Carl M.;
Petersen, Cordula;
Gale, Davina;
Emeribe, Ugochinyere A.;
Georgoulia, Nefeli;
Perez, Ignacio E. Diaz;
Spicer, Jonathan D.

Publication type:

Article

Bevacizumab for Brain Radiation Necrosis in Patients With Nonsquamous Nonsmall Cell Lung Cancer.

Published in:

Clinical Lung Cancer, 2024, v. 25, n. 6, p. 581, doi. 10.1016/j.cllc.2024.06.010

By:

Daisuke Shibahara;
Kentaro Tanaka;
Osamu Togao;
Yoshimasa Shiraishi;
Yasuto Yoneshima;
Eiji Iwama;
Tadamasa Yoshitake;
Kousei Ishigami;
Isamu Okamoto

Publication type:

Article

Tepotinib in a Patient With Advanced Non-Small Cell Lung Cancer Harboring MET Exon 14 Skipping Undergoing Concomitant Hemodialysis for Renal Failure: A Case Report.

Published in:

Clinical Lung Cancer, 2024, v. 25, n. 6, p. 577, doi. 10.1016/j.cllc.2024.05.008

By:

Kleemiss, Moritz;
Muller, Christa E.;
Schneider, Marion;
Strotmann, Rainer;
Orlowski, Katrin;
Goteti, Kosalaram;
Yanik, Mert;
Brossart, Peter;
Bauernfeind, Franz-Georg

Publication type:

Article

Genomic and Immune Landscape Comparison of MET Exon 14 Skipping and MET-Amplified Non-small Cell Lung Cancer.

Published in:

Clinical Lung Cancer, 2024, v. 25, n. 6, p. 567, doi. 10.1016/j.cllc.2024.05.001

By:

Minne, Rachel L.;
Luo, Natalie Y.;
Traynor, Anne M.;
Minxuan Huang;
DeTullio, Luisina;
Godden, Jen;
Stoppler, Melissa;
Kimple, Randall J.;
Baschnagel, Andrew M.

Publication type:

Article

Factors Associated With Margin Positivity After Lung Resection Surgery.

Published in:

Clinical Lung Cancer, 2024, v. 25, n. 6, p. 560, doi. 10.1016/j.cllc.2024.03.007

By:

Rshaidat, Hamza;
Whitehorn, Gregory L.;
Collins, Micaela;
Mack, Shale J.;
Martin, Jonathan;
Grenda, Tyler R.;
Evans III, Nathaniel R.;
Okusanya, Olugbenga T.

Publication type:

Article

Molecular Characteristics and Pretreatment Neutrophil-to-Lymphocyte Ratio as Predictors of Durable Clinical Benefit from Immune Checkpoint Inhibition in Non-Small Cell Lung Cancer.

Published in:

Clinical Lung Cancer, 2024, v. 25, n. 6, p. 550, doi. 10.1016/j.cllc.2024.06.006

By:

Shah, Arpeet T.;
Blanchard, Isabelle;
Padda, Sukhmani K.;
Wakelee, Heather A.;
Neal, Joel W.

Publication type:

Article

Surgery and Stereotactic Radiotherapy for Stage I Small-Cell Lung Carcinoma: A 25-Year Experience.

Published in:

Clinical Lung Cancer, 2024, v. 25, n. 6, p. 537, doi. 10.1016/j.cllc.2024.06.001

By:

Robinson, Lary A.;
Tanvetyanon, Tawee;
Robinson, Noah A.;
Bryant, Sandra;
Bailey, Alexis;
Reed, Damon R.;
Dilling, Thomas

Publication type:

Article

Prediction of Pleural Lavage Cytology According to Thin-Section Computed Tomography in Non-Small-Cell Lung Cancer.

Published in:

Clinical Lung Cancer, 2024, v. 25, n. 6, p. 529, doi. 10.1016/j.cllc.2024.04.010

By:

Yuto Nonaka;
Mitsuhiro Isaka;
Keigo Matsushima;
Shinya Katsumata;
Hayato Konno;
Tetsuya Mizuno;
Toshiyuki Nagata;
Akifumi Notsu;
Kiyoshi Tone;
Takuya Kawata;
Masahiro Endo;
Yasuhisa Ohde

Publication type:

Article

Clinicopathological Features and Survival Outcomes of Resected Lung Adenosquamous Carcinoma: Results From a Nationwide Japanese Registry Data.

Published in:

Clinical Lung Cancer, 2024, v. 25, n. 6, p. 519, doi. 10.1016/j.cllc.2024.05.010

By:

Tomoyuki Hishida;
Jiro Okami;
Hisao Asamura;
Etsuo Miyaoka;
Yasushi Shintani;
Mitsutaka Kadokura;
Shunsuke Endo;
Masayuki Chida;
Hidemi Suzuki;
Ichiro Yoshino;
Hiroshi Date

Publication type:

Article

Patients' Preferences for Adjuvant Osimertinib in Non-Small-Cell Lung Cancer After Complete Surgical Resection: What Makes It Worth It to Patients?

Published in:

Clinical Lung Cancer, 2024, v. 25, n. 6, p. 509, doi. 10.1016/j.cllc.2024.05.003

By:

Awidi, Muhammad;
Mier-Hicks, Angel;
Perimbeti, Stuthi;
Attwood, Kristopher;
Hongbin Chen;
Jain, Prantesh;
Yau, Edwin;
Early, Amy;
Dy, Grace K.

Publication type:

Article

5-Year Real-World Outcomes With Frontline Pembrolizumab Monotherapy in PD-Ll Expression 2 50% Ad vance d NSCLC.

Published in:

Clinical Lung Cancer, 2024, v. 25, n. 6, p. 502, doi. 10.1016/j.cllc.2024.05.002

By:

Velcheti, Vamsidhar;
Rai, Pragya;
Yu-Han Kao;
Chirovsky, Diana;
Nunes, Ana Tablante;
Liu, Stephen V.

Publication type:

Article

The Emerging Role of Immune Checkpoint Blockade for the Treatment of Lung Cancer Brain Metastases.

Published in:

Clinical Lung Cancer, 2024, v. 25, n. 6, p. 483, doi. 10.1016/j.cllc.2024.06.004

By:

Xiancheng Wu;
Stabile, Laura R.;
Burns, Timothy E.

Publication type:

Article